Page last updated: 2024-08-25

nedaplatin and Neoplasms

nedaplatin has been researched along with Neoplasms in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's3 (27.27)18.2507
2000's1 (9.09)29.6817
2010's4 (36.36)24.3611
2020's2 (18.18)2.80

Authors

AuthorsStudies
Harasawa, H; Hashizume, J; Kodama, Y; Nakagawa, H; Nambu, M1
Kong, Y; Li, X; Liu, W; Liu, X; Mu, X; Pang, J1
Hou, A; Jiang, Z; Liu, W; Mu, Y; Tan, S; Yu, C1
Fong, CW1
Ando, Y; Araki, R; Iwamizu, H; Kataoka, T; Kumakura, Y; Miyazaki, M; Nagai, T; Yamada, K1
Huang, XE; Jiang, Y; Li, Y; Xiang, J; Yan, PW1
Ishibashi, T; Oguma, T; Yano, Y1
Christian, MC1
Ariyoshi, Y; Inuyama, Y; Kimura, I; Majima, H; Niitani, H; Ogawa, M; Ota, K; Taguchi, T; Wakui, A; Yoshida, O1
Amano, T; Eguchi, K; Kojima, A; Morita, M; Ohe, Y; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T1
Ariyoshi, Y; Ota, K1

Reviews

1 review(s) available for nedaplatin and Neoplasms

ArticleYear
The current status of new platinum analogs.
    Seminars in oncology, 1992, Volume: 19, Issue:6

    Topics: Animals; Antineoplastic Agents; Carboplatin; Chemistry, Pharmaceutical; Cyclobutanes; Drugs, Investigational; Forecasting; Humans; Neoplasms; Organoplatinum Compounds; Oxaliplatin

1992

Trials

3 trial(s) available for nedaplatin and Neoplasms

ArticleYear
Shen-Cao granules formulated based on traditional Chinese medicine alleviates bone marrow suppression caused by platinum-based anticancer reagents.
    Medicine, 2017, Volume: 96, Issue:19

    Topics: Adult; Aged; Antineoplastic Agents; Blood Platelets; Bone Marrow; Bone Marrow Diseases; Carboplatin; Cisplatin; Drug Therapy, Combination; Female; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Neoplasms; Organoplatinum Compounds; Platelet Activation; Platelet Aggregation; Platinum Compounds; Thrombocytopenia; Young Adult

2017
Efficacy and safety of endostar combined with chemotherapy in patients with advanced solid tumors.
    Asian Pacific journal of cancer prevention : APJCP, 2010, Volume: 11, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Deoxycytidine; Docetaxel; Endostatins; Female; Fluorouracil; Gemcitabine; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Recombinant Proteins; Survival Rate; Taxoids; Treatment Outcome

2010
Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion.
    Cancer research, 1991, Mar-01, Volume: 51, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Organoplatinum Compounds

1991

Other Studies

7 other study(ies) available for nedaplatin and Neoplasms

ArticleYear
Poor Renal Function and a High Modified Glasgow Prognostic Score Are Predictive Factors for Nedaplatin/5-Fluorouracil Combination Therapy-induced Febrile Neutropenia.
    Anticancer research, 2023, Volume: 43, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Febrile Neutropenia; Fluorouracil; Granulocyte Colony-Stimulating Factor; Mice; Neoplasms; Prognosis; Retrospective Studies

2023
Galactosylated Chitosan Modified Magnetic Mesoporous Silica Nanoparticles Loaded with Nedaplatin for the Targeted Chemo-Photothermal Synergistic Therapy of Cancer.
    Journal of nanoscience and nanotechnology, 2021, 09-01, Volume: 21, Issue:9

    Topics: Cell Line, Tumor; Chitosan; Doxorubicin; Drug Delivery Systems; Drug Liberation; Magnetic Phenomena; Nanoparticles; Neoplasms; Organoplatinum Compounds; Phototherapy; Porosity; Silicon Dioxide

2021
Platinum based radiochemotherapies: Free radical mechanisms and radiotherapy sensitizers.
    Free radical biology & medicine, 2016, Volume: 99

    Topics: Antineoplastic Agents; Carboplatin; Chemoradiotherapy; Cisplatin; DNA Adducts; DNA Damage; Drug Synergism; Electrons; Fluorouracil; Free Radicals; Humans; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Oxidation-Reduction; Radiation-Sensitizing Agents

2016
[Analysis of Nedaplatin Dose in Patients with Impaired Renal Function].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Neoplasms; Organoplatinum Compounds; Retrospective Studies; Risk Factors

2017
A formula for predicting optimal dosage of nedaplatin based on renal function in adult cancer patients.
    Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Dose-Response Relationship, Drug; Female; Forecasting; Humans; Kidney; Male; Middle Aged; Models, Theoretical; Neoplasms; Organoplatinum Compounds; Regression Analysis

2002
[Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Kidney; Lung Neoplasms; Male; Middle Aged; Neoplasms; Organoplatinum Compounds; Prostatic Neoplasms

1992
[Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:4 Pt 2-2

    Topics: Animals; Antineoplastic Agents; Bone Marrow; Carboplatin; Cisplatin; Drug Evaluation; Drug Screening Assays, Antitumor; Humans; Kidney; Leukopenia; Mice; Neoplasms; Neoplasms, Experimental; Organoplatinum Compounds; Thrombocytopenia

1989